However, due to advertising on social media there has been a resurgence of people using products that contain Melanotan II, such as injections and nasal sprays
Objective: To estimate the effect of GLP-1RAs versus sodiumglucose cotransporter-2 inhibitors (SGLT2is) and dipeptidyl peptidase-4 inhibitors (DPP4is) on risk for ION
Transplantation of gut microbiota derived from Alzheimer's disease mouse model impairs memory function and neurogenesis in C57BL/6 mice
Frontiers in Cell and Developmental Biology, 9 , 626404
What's at Stake: Employers' benefit budgets and access decisions face pressure from rising GLP1 costs

You should contact your GP or prescriber if : You experience significant difficulty eating or maintaining adequate nutrition Your weight loss exceeds 0.51 kg per week consistently after the initial treatment period You develop persistent nausea, vomiting, or abdominal pain You notice significant changes in heart rate, palpitations, or blood pressure readings Sleep disturbances worsen or become unmanageable You experience mood changes, increased anxiety, or depression Side effects from either medication become intolerable You're considering adjusting the dose of either medication You are planning a pregnancy or become pregnant Before starting combined therapy , ensure your prescriber is aware of: Your complete medication list, including over-the-counter medicines and supplements Your full medical history, particularly cardiovascular, gastrointestinal, and psychiatric conditions Any history of eating disorders or disordered eating patterns Previous responses to appetite-suppressant medications Your weight management goals and expectations Family planning and contraception needs Regular monitoring appointments are important for assessing: Weight loss trajectory and body composition changes Nutritional status and dietary adequacy Cardiovascular parameters (blood pressure, heart rate) Mental health and wellbeing Effectiveness of ADHD management Blood glucose levels (particularly if you have diabetes or prediabetes) Liver and kidney function as clinically indicated NICE guidance on obesity management (TA875) and ADHD (NG87) emphasises the importance of comprehensive care
